Presence of SARS-CoV-2 Antibodies in Spent Peritoneal Dialysate.
作者信息
Wang Xiaoling, Grobe Nadja, Patel Amrish, Sharma Shuchita, Uribarri Jaime, Kotanko Peter
机构信息
Research Division, Renal Research Institute, New York, New York.
Department of Medicine, Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.
出版信息
J Am Soc Nephrol. 2021 Aug;32(8):1865-1867. doi: 10.1681/ASN.2021020161. Epub 2021 Jul 6.
Abstract
摘要
相似文献
1
Presence of SARS-CoV-2 Antibodies in Spent Peritoneal Dialysate.新冠病毒抗体在腹膜透析废液中的存在情况。
J Am Soc Nephrol. 2021 Aug;32(8):1865-1867. doi: 10.1681/ASN.2021020161. Epub 2021 Jul 6.
2
Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection.感染后六个月血液透析患者中抗SARS-CoV-2 IgG抗体的动力学
J Am Soc Nephrol. 2021 May 3;32(5):1033-1036. doi: 10.1681/ASN.2020111618. Epub 2021 Feb 26.
3
[Not Available].[无可用内容]
Rev Med Suisse. 2021 Jan 27;17(723):234.
4
A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.用于 SARS-CoV-2 感染的多重非侵入性唾液抗体检测及其在基于邮件的人群调查中的应用。
Microbiol Spectr. 2021 Oct 31;9(2):e0069321. doi: 10.1128/Spectrum.00693-21. Epub 2021 Sep 15.
5
SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.SARS-CoV-2 抗体检测在医护人员中的应用：三种市售抗体检测试剂盒的临床性能比较。
Microbiol Spectr. 2021 Oct 31;9(2):e0039121. doi: 10.1128/Spectrum.00391-21. Epub 2021 Sep 29.
6
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征（MIS-C）中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
7
A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.一种双抗原酶联免疫吸附测定法可用于评估低传播环境中严重急性呼吸综合征冠状病毒 2 抗体的血清流行率。
J Infect Dis. 2021 Jan 4;223(1):10-14. doi: 10.1093/infdis/jiaa623.
8
Profile of specific antibodies to the SARS-CoV-2.SARS-CoV-2 特异性抗体谱。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001335. Epub 2021 Mar 18.
9
SARS-CoV-2 antibodies: Comparison of three high-throughput immunoassays versus the neutralization test.严重急性呼吸综合征冠状病毒2型抗体：三种高通量免疫测定法与中和试验的比较
Eur J Clin Invest. 2021 Jul;51(7):e13573. doi: 10.1111/eci.13573. Epub 2021 May 5.
10
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study.非重症 COVID-19 患者中持续的 SARS-CoV-2 核衣壳抗体水平：一项基于人群的研究。
Clin Chem Lab Med. 2020 Nov 19;59(2):e49-e51. doi: 10.1515/cclm-2020-1347.
引用本文的文献
1
Clinical outcomes of COVID-19 in patients undergoing chronic hemodialysis and peritoneal dialysis.COVID-19 患者在进行慢性血液透析和腹膜透析治疗的临床结果。
J Bras Nefrol. 2022 Oct-Dec;44(4):505-510. doi: 10.1590/2175-8239-JBN-2021-0261en.
2
Humoral response to BNT162b2 mRNA COVID-19 vaccine in peritoneal and hemodialysis patients: A comparative study.腹膜透析和血液透析患者对 BNT162b2 mRNA COVID-19 疫苗的体液反应：一项比较研究。
Ther Apher Dial. 2022 Aug;26(4):790-796. doi: 10.1111/1744-9987.13766. Epub 2021 Dec 14.
本文引用的文献
1
SARS-CoV-2 in Spent Dialysate from Chronic Peritoneal Dialysis Patients with COVID-19.SARS-CoV-2 在 COVID-19 慢性腹膜透析患者的废弃透析液中。
Kidney360. 2020 Dec 1;2(1):86-89. doi: 10.34067/KID.0006102020. eCollection 2021 Jan 28.
2
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
3
Detection of SARS-CoV-2 Antibodies in Oral Fluid Obtained Using a Rapid Collection Device.使用快速采集装置从口腔液中检测 SARS-CoV-2 抗体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02510-20.
4
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.美国大型全国范围内透析患者样本中 SARS-CoV-2 抗体的流行情况：一项横断面研究。
Lancet. 2020 Oct 24;396(10259):1335-1344. doi: 10.1016/S0140-6736(20)32009-2. Epub 2020 Sep 25.
5
High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.使用血清学筛查检测到血液透析患者中无症状 COVID-19 感染的高发生率。
J Am Soc Nephrol. 2020 Sep;31(9):1969-1975. doi: 10.1681/ASN.2020060827. Epub 2020 Jul 30.
6
Coronavirus disease 2019 (COVID-19) hospitalized patients with acute kidney injury treated with acute peritoneal dialysis do not have infectious peritoneal dialysis effluent.2019年冠状病毒病（COVID-19）合并急性肾损伤的住院患者接受急性腹膜透析治疗时，其腹膜透析流出液无感染情况。
Kidney Int. 2020 Sep;98(3):782. doi: 10.1016/j.kint.2020.06.012. Epub 2020 Jun 24.
7
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎（COVID-19）患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
8
Protein losses during peritoneal dialysis.腹膜透析过程中的蛋白质丢失
Kidney Int. 1981 Apr;19(4):593-602. doi: 10.1038/ki.1981.57.
Zotero 插件